Bone Growth Stimulator Market Report Is Anticipated To Register Around 5.30 percent CAGR From 2024-2032 - WhaTech
| 066700 Stock | KRW 3,030 10.00 0.33% |
About 55% of Theragen Etex's investor base is interested to short. The analysis of current outlook of investing in Theragen Etex CoLtd suggests that many traders are impartial regarding Theragen Etex's prospects. The current market sentiment, together with Theragen Etex's historical and current headlines, can help investors time the market. In addition, many technical investors use Theragen Etex CoLtd stock news signals to limit their universe of possible portfolio assets.
Theragen |
Bone Growth Stimulator Market Report Is Anticipated To Register Around 5.30 percent CAGR From 2024-2032 WhaTech
Read at news.google.com
 |
Theragen Etex Fundamental Analysis
We analyze Theragen Etex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theragen Etex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theragen Etex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Theragen Etex is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Theragen Etex CoLtd Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theragen Etex stock to make a market-neutral strategy. Peer analysis of Theragen Etex could also be used in its relative valuation, which is a method of valuing Theragen Etex by comparing valuation metrics with similar companies.
Peers
Theragen Etex Related Equities
| 119500 | Formetal | 4.63 | ||||
| 000400 | Lotte Non | 0.46 | ||||
| 037330 | Inzi Display | 0.22 | ||||
| 004430 | Songwon Industrial | 0.80 | ||||
| 024840 | Kbi Metal | 1.59 | ||||
| 109860 | Dongil Metal | 3.47 | ||||
| 008250 | Eagon Industrial | 8.26 |
Complementary Tools for Theragen Stock analysis
When running Theragen Etex's price analysis, check to measure Theragen Etex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theragen Etex is operating at the current time. Most of Theragen Etex's value examination focuses on studying past and present price action to predict the probability of Theragen Etex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theragen Etex's price. Additionally, you may evaluate how the addition of Theragen Etex to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |